Torres, Mark Jezer .

HRN: 27-39-92  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/05/2026
02/11/2026
IVTT
4.5 G
Q6
Cap-MR
Pending Pharmacy Acceptance 

 Indication:  EmpiricEmpirical Escalation    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: